Overview
Lobbying Costs
400,000€ - 499,999€
Financial year: Jan 2022 - Dec 2022
Lobbyists (Full time equivalent)
8.5 Fte (10)
Lobbyists with EP accreditation
0
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
Fundación para la Investigación del Hospital Clínico de la Comunidad Valenciana (INCLIVA)
EU Transparency Register
952623650487-34 First registered on 14 Jun 2023
Goals / Remit
The purpose of the INCLIVA Foundation is:
*To establish the strategic guidelines, prioritise and promote and execute biomedical research at the University Clinical Hospital and its Health Department.
*To facilitate and promote the teaching and preparation of postgraduates and researchers for their continuing education, complementing the general plans for specialised medical teaching accredited at the Hospital Clínico Universitario, and the existing postgraduate teaching programmes at the University.
*To accredit and guarantee the research projects and progress of the Hospital Clínico Universitario and its Health Department.
*To cooperate by means of Agreements and other forms of agreement with national and international organisations and with national or foreign health or teaching institutions.
*To project to society the experience and the potential for responsible and relevant contribution of the University Clinical Hospital and its Health Department.
*To lead and/or part (...)Main EU files targeted
The European Commission is legislating on health issues which are the main objective of the INCLIVA Foundation, so we are very interested in: HEurope (Pilar 1 and 2, clusters 1 and 4, missions, etc), EU4Heatlh, IHI and research policies in general on issues of digital technologies and health.
Address
Head Office
Av. Menéndez y Pelayo, 4 acc
Valencia 46010
SPAINEU Office
Av. Menéndez y Pelayo, 4 acc
Valencia 46010
SPAINWebsite
-
People
Total lobbyists declared
10
Employment time Lobbyists 100% 6 75% 2 50% 2 Lobbyists (Full time equivalent)
8.5
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
We are only dedicated to the health sector as a whole, and, for us, the research lines asked by the EC in their enquires or the EC public consultations for its policies are very important and we are very active on it. We are very conscientious with improving the EU health policies and interests. For example, we have been part of studies for COVID-19 for the new vaccines, we have personnel who are advisors in the CE, all our labour is orientated to improve the European Health sector.
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Think tanks and research institutions
-
Networking
Affiliation
Incliva belongs to the following European platforms:
The Big Data Value Association (BDVA) is an industry-driven organisation to develop an innovation ecosystem that enables the data-driven digital transformation of the economy and society in Europe. (https://www.bdva.eu/)
the European Advanced Translational Research Infrastructure to joint resources and services for research communities to translate scientific discoveries into benefits for patients. It is a non-profit European Research Infrastructure Consortium to facilitate the joint establishment and operation of research infrastructures of European interest, providing access to a vast array of pre-clinical and clinical expertise and facilities that are available within 144+ top-tier academic centres across Europe, to improve and optimise preclinical and early clinical development of drugs, vaccines and diagnostics. Developing solutions in the fields of advanced therapy medicinal products, imaging and tracing, small molecules, vaccines and biomarkers. (https://eatris.eu)
EU-OPENSCREEN is a not-for-profit European Research Infrastructure Consortium (ERIC) for chemical biology and early drug discovery that supports all stages of a chemical tool development project, including assay adaptation, high-throughput screening, and chemical optimisation of the ‘hit’ compounds, strengthening the global scientific and economic competitiveness of Europe through delivering public health benefits. It also collaborates with 2 other research infrastructures such as ESFRI and Euro-BioImaging. (https://www.eu-openscreen.eu/)
The Worldwide Innovative Networking (WIN) Consortium in personalized cancer medicine is a non-profit, non-governmental organization leading by the cancer centers worldwide to accelerate the pace and reduce the cost of translating novel cancer treatments to the bedside by developing and applying, through worldwide clinical trials and research projects, the most promising advances in genomic-based cancer research, increasing the efficacy of cancer diagnostics and therapeutics by understanding the genetics and biology of each individual’s tumor and accounting for genetic differences across diverse populations. (( https://winconsortium.org/)Member organisations
Incliva belongs to:
REGIC is the first association of clinical research management entities created in Spain at the request of professionals, with the aim of sharing experiences and creating a space for interaction and training in the management of health R&D&I https://regic.org/
CIBER: (Network of Centres for Biomedical Research) The Carlos III Health Institute develops - through the General Subdirection of Networks and Centers for the Cooperative Research - the creation of stable research network structures such as CIBER (Network of Centres for Biomedical Research). INCLIVA participates in this research structure through its associated groups. https://www.ciberisciii.es/
ITEMAS: The Platform for Dynamisation and Innovation of the industrial capacities of the National Health System and their effective transfer to the productive sector (ITEMAS) is one of the platforms of the Carlos III Institute of Health (ISCIII) to support R&D&I in Biomedicine and Health Sciences. Its objective is to effectively boost the industrial capacity generated by the National Health System and the real transfer of the results of research carried out within the National Health System to the productive sector. To this end, it has its own impact programme to accelerate the industrialisation and adoption of the innovations arising from the National Health System centres. www.itemas.org -
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Jan 2022 - Dec 2022
Lobbying costs for closed financial year
400,000€ - 499,999€
Major contributions in closed year
None declared
Intermediaries for closed year
None declaredIntermediaries for current year
None declaredClosed year Costs
400,000€ - 499,999€
Other financial info
The data taken into account are for the closed fiscal exercise 2022, INCLIVA is a research institution only dedicated to improve to the health sector as a whole and very conscientious with improving the EU health policies and interests.
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
Artificial intelligence and digital#Cancer
Communication activities
INCLIVA is very active attending to CE events and produces InfoDays, webinars, etc. in its area of interest, the health sector, both in person and online, and part of the staff acts as experts (evaluation assesment, advisor, ...).
Other activities
None declared
Meetings
Meetings
None declared